Summary From the point of view of biomedicine, to highlight the evolution of acute hepatitis in children; Lilly’s announcement of a drug to tackle obesity that could compete with bariatric surgery; and the analysis of the New England Journal of Medicine on the “boosters” for covid. As far as Global Health is concerned, we […]
Summary From the point of view of biomedicine, to highlight the new devices that read the brain (brain-reading-devices) and allow movement, touch and speech to be recovered. Also the great future of liquid biopsy in the early diagnosis of cancer. As far as Global Health is concerned, there is no choice but to quote Bill […]
SUMMARY From the point of view of biomedicine, it is important to highlight the fact that greater access to antibiotics (reduced in many countries) is a basic element to overcome the pandemic of resistance to these drugs. Cases of acute hepatitis in children, detected in the United Kingdom and also in Spain, have […]
SUMMARY From the point of view of biomedicine, it is worth highlighting the fact, highlighted by the journal Nature, that the WHO took more than two years to recognize the airborne transmission of covid. A new generation of vaccines that prevent cancer can make tumors disappear before they appear, according to an article in […]
SUMMARY From the point of view of biomedicine, the publication in Science that completes the analysis of the human genome should be highlighted, which seems to open the door to the therapy of various diseases. As far as Global Health is concerned, polio reappearance in Malawi is of concern. As for international health policy, […]
SUMMARY From the point of view of biomedicine, the progress in the treatment of breast cancer should be highlighted, according to the article published by the NEJM, with a brake of around 80% of this advanced cancer and makes it disappear in 16%. . As far as Global Health is concerned, there are undiagnosed […]
See PDF of the presentation used during the breakfast: Presentacion SegurCaixa Adeslas JM 20220322 v7 Breakfast-debate with Mr. Javier Murillo Ferrer, General Manager of SegurCaixa Adeslas A little history Adelas has been a leader in health insurance for more than 20 years. In 2009 this company was acquired by La Caixa, to […]
SUMMARY From the point of view of biomedicine, to highlight the new treatment for malaria in children; the new variant “Delatacron”, similar to the “ómicron”; and, the possibilities of artificial intelligence to accelerate the appearance of new medicines. We would like to underline the studies promoted by Valentín Fuster on ultrasound of the neck […]
See PDF of the presentation: Presentación Barcelona 15 marzo, 2022 On March 15, 2022, jointly organized by BIOSIM and the Consorci Social y Sanitario de Catalunya, a session on shared gains took place. In the course of this session I had the opportunity to make the attached presentation on shared gains for […]
SUMMARY From the point of view of Biomedicine, the Lancet report on risk factors in COPD (chronic obstructive pulmonary disease), one of the great burdens of all health systems, should be highlighted. Also the finding that COVID can cause brain damage, although its scope is yet to be determined. As for Global Health, it […]
